Literature DB >> 480147

Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

S E Tsuei, R G Moore, J J Ashley, W G McBride.   

Abstract

The pharmacokinetics of dexamethasone alcohol is described in six male and six female healthy adult volunteers who each received 8 mg of dexamethasone phosphate by bolus intravenous injection. Quantitation of the alcohol was done using a high-performance liquid chromatographic method with improved specificity. Statistical evaluation of the results generated by nonlinear least-squares regression analysis of the plasma concentration-time data shows that the phosphate ester is very rapidly hydrolyzed to the alcohol and a biexponential equation is the simplest polyexponential equation that is consistent with the data. The terminal phase half-life t1/2 beta was significantly greater (P less than 0.05) in males (mean 201.5 min) than in females (mean 142.3 min). They prolonged t1/2 beta in males did not appear to be caused by an impaired capacity to eliminate dexamethasone since the total plasma clearance did not differ between males (mean 24.5 ml/min) and females (mean 242.9 ml/min). There was, however, a high positive correlation between t1/2 beta and Vdss among the 12 adults (r = 0.92, p less than 0.001). There were also significant correlation between Vdss and body weight (r = 0.67, p less than 0.05) and t1/2 beta and body weight (r = 0.80, p less than 0.01). The difference in body weight between the sexes seems to be the main factor contributing to the difference observed in t1/2 beta. An average of only 2.6% of the dose was found unchanged in a 24-hr urine sample, and hence it appears that dexamethasone is primarily eliminated by extrarenal, probably hepatic, mechanisms.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 480147     DOI: 10.1007/bf01060016

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  17 in total

1.  Bioavailability of oral dexamethasone.

Authors:  D E Duggan; K C Yeh; N Matalia; C A Ditzler; F G McMahon
Journal:  Clin Pharmacol Ther       Date:  1975-08       Impact factor: 6.875

2.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

3.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

4.  Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy.

Authors:  E Caspi; P Schreyer; Z Weinraub; R Reif; I Levi; G Mundel
Journal:  Br J Obstet Gynaecol       Date:  1976-03

5.  Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma.

Authors:  S M Brooks; E E Werk; S J Ackerman; I Sullivan; K Thrasher
Journal:  N Engl J Med       Date:  1972-05-25       Impact factor: 91.245

6.  Clearance and biologic half-life as indices of intrinsic hepatic metabolism.

Authors:  D Perrier; M Gibaldi
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

7.  Radioimmunoassay for dexamethasone in plasma.

Authors:  M Hichens; A F Hogans
Journal:  Clin Chem       Date:  1974-02       Impact factor: 8.327

8.  Bioavailability of dexamethasone. II. Dexamethasone phosphate.

Authors:  L E Hare; K C Yeh; C A Ditzler; F G McMahon; D E Duggan
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

9.  Studies on dexamethasone metabolism in man: effect of diphenylhydantoin.

Authors:  N Haque; K Thrasher; E E Werk; H C Knowles; L J Sholiton
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

10.  A radioimmunoassay procedure for dexamethasone: plasma and urine levels in man.

Authors:  J English; J Chakraborty; V Marks; A Parke
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

View more
  32 in total

Review 1.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

Review 2.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

3.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

4.  A survey of pharmacokinetic data from pregnant women.

Authors:  A J Cummings
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

5.  Influence of phenylbutazone, mofebutazone and aspirin on the pharmacokinetics of dexamethasone in the rat.

Authors:  M A Kassem; K E Schulte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

6.  Effect of betamethasone on airway obstruction and bronchial response to salbutamol in prednisolone resistant asthma.

Authors:  B Grandordy; N Belmatoug; A Morelle; D De Lauture; J Marsac
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

Review 7.  Clinical pharmacokinetic considerations in the treatment of increased intracranial pressure.

Authors:  G Heinemeyer
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

8.  The pharmacokinetics of single high doses of dexamethasone in cancer patients.

Authors:  M E Brady; G P Sartiano; S L Rosenblum; N E Zaglama; C T Bauguess
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Pharmacokinetics of betamethasone in healthy adults after intravenous administration.

Authors:  M C Petersen; R L Nation; W G McBride; J J Ashley; R G Moore
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

10.  Disposition of betamethasone in parturient women after intravenous administration.

Authors:  M C Petersen; C B Collier; J J Ashley; W G McBride; R L Nation
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.